Basic Information
| RNALocate ID: | RLID:11002339 |
| RNA Symbol: | hsa-miR-29c-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-29c |
| RNA ID: | miRBase:MIMAT0000681 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24009880 |
| Tissue/Cell Line: | Human mast cell line (HMC-1) |
| Method: | Microarray |
| Description: | In the exosomes, 116 microRNAs were identified and 134 microRNAs were identified in the donor HMC-1 cells (Fig. 3a and 3b, Table I and Additional Information, Table S16). Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001983 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001984 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001985 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11002331 | Exosome | Serum | 18589210 |
| RLID:11002332 | Exosome | Saliva | 19627513 |
| RLID:11002333 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11002334 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002335 | Exosome | Renal cancer cells | 21670082 |
| RLID:11002336 | Exosome | Breast milk | 22211110 |
| RLID:11002337 | Exosome | Brain tissue | 23382797 |
| RLID:11002338 | Exosome | Plasma | 23663360 |
| RLID:11002340 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11002341 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11002342 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000108 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Mast cells|Seminal fluid | |
| RLID-D:11000395 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-29c-3p | Diffuse large b cell lymphoma | MNDR-E-MI-35448 |
| MNDR | hsa-miR-29c-3p | Splenic marginal zone lymphoma | MNDR-E-MI-35449 |
| MNDR | hsa-miR-29c-3p | Oral squamous cell carcinoma | MNDR-E-MI-35450 |
| MNDR | hsa-miR-29c-3p | Large cell neuroendocrine cancer | MNDR-E-MI-35451 |
| MNDR | hsa-miR-29c-3p | B cell lymphoma of malt type | MNDR-E-MI-35452 |
| MNDR | hsa-miR-29c-3p | Small intestinal neuroendocrine tumor | MNDR-E-MI-35453 |
| MNDR | hsa-miR-29c-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-35454 |
| MNDR | hsa-miR-29c-3p | Ovarian clear cell carcinoma | MNDR-E-MI-35455 |
| MNDR | hsa-miR-29c-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-35456 |
| MNDR | hsa-miR-29c-3p | Lymphoma | MNDR-E-MI-35457 |
| MNDR | hsa-miR-29c-3p | Lymphoma non-hodgkin | MNDR-E-MI-35458 |
| MNDR | hsa-miR-29c-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-35459 |
| MNDR | hsa-miR-29c-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-35460 |
| MNDR | hsa-miR-29c-3p | Breast cancer luminal b | MNDR-E-MI-35461 |
| MNDR | hsa-miR-29c-3p | Niemann-pick disease type c | MNDR-E-MI-35462 |
| MNDR | hsa-miR-29c-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-35463 |
| MNDR | hsa-miR-29c-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-35464 |
| MNDR | hsa-miR-29c-3p | Small intestine cancer | MNDR-E-MI-35465 |
| MNDR | hsa-miR-29c-3p | Dermatomyositis | MNDR-E-MI-35466 |
| MNDR | hsa-miR-29c-3p | Prostate cancer | MNDR-E-MI-35467 |
| MNDR | hsa-miR-29c-3p | Gastric cancer | MNDR-E-MI-35468 |
| MNDR | hsa-miR-29c-3p | Gastric lymphoma | MNDR-E-MI-35469 |
| MNDR | hsa-miR-29c-3p | Alzheimer disease | MNDR-E-MI-35470 |
| MNDR | hsa-miR-29c-3p | Intracranial aneurysm | MNDR-E-MI-35471 |
| MNDR | hsa-miR-29c-3p | Urinary bladder cancer | MNDR-E-MI-35472 |
| MNDR | hsa-miR-29c-3p | Esophageal carcinoma | MNDR-E-MI-35473 |
| MNDR | hsa-miR-29c-3p | Dysautonomia familial | MNDR-E-MI-35474 |
| MNDR | hsa-miR-29c-3p | Myotonic dystrophy | MNDR-E-MI-35475 |
| MNDR | hsa-miR-29c-3p | Duchenne muscular dystrophy | MNDR-E-MI-35476 |
| MNDR | hsa-miR-29c-3p | Head and neck cancer | MNDR-E-MI-35477 |
| MNDR | hsa-miR-29c-3p | Leukemia | MNDR-E-MI-35478 |
| MNDR | hsa-miR-29c-3p | Huntington disease | MNDR-E-MI-35479 |
| MNDR | hsa-miR-29c-3p | Cardiovascular disease | MNDR-E-MI-35480 |
| MNDR | hsa-miR-29c-3p | Moyamoya disease | MNDR-E-MI-35481 |
| MNDR | hsa-miR-29c-3p | Uterine fibroid | MNDR-E-MI-35482 |
| MNDR | hsa-miR-29c-3p | Lung cancer | MNDR-E-MI-35483 |
| MNDR | hsa-miR-29c-3p | Down syndrome | MNDR-E-MI-35484 |
| MNDR | hsa-miR-29c-3p | Parkinson disease | MNDR-E-MI-35485 |
| MNDR | hsa-miR-29c-3p | Niemann-pick disease | MNDR-E-MI-35486 |
| MNDR | hsa-miR-29c-3p | Breast cancer | MNDR-E-MI-35487 |
| MNDR | hsa-miR-29c-3p | Thyroid cancer | MNDR-E-MI-35488 |
| MNDR | hsa-miR-29c-3p | Pancreatic cancer | MNDR-E-MI-35489 |
| MNDR | hsa-miR-29c-3p | HCV | MNDR-E-MI-35490 |
| MNDR | hsa-miR-29c-3p | Melanoma | MNDR-E-MI-35491 |
| MNDR | hsa-miR-29c-3p | Rectum adenocarcinoma | MNDR-E-MI-35492 |
| MNDR | hsa-miR-29c-3p | Nephroblastoma | MNDR-E-MI-35493 |
| MNDR | hsa-miR-29c-3p | Colon cancer | MNDR-E-MI-35494 |
| MNDR | hsa-miR-29c-3p | Ischemic attack transient | MNDR-E-MI-35495 |
| MNDR | hsa-miR-29c-3p | Colon adenocarcinoma | MNDR-E-MI-35496 |
| MNDR | hsa-miR-29c-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-35497 |
| MNDR | hsa-miR-29c-3p | Familial ovarian cancer | MNDR-E-MI-35498 |
| MNDR | hsa-miR-29c-3p | Prostate adenocarcinoma | MNDR-E-MI-35499 |
| MNDR | hsa-miR-29c-3p | Kidney cancer | MNDR-E-MI-35500 |
| MNDR | hsa-miR-29c-3p | Endometriosis | MNDR-E-MI-35501 |
| MNDR | hsa-miR-29c-3p | Thyroid adenomas | MNDR-E-MI-35502 |
| MNDR | hsa-miR-29c-3p | Invasive ductal carcinoma | MNDR-E-MI-35503 |
| MNDR | hsa-miR-29c-3p | Glioblastoma | MNDR-E-MI-35504 |
| MNDR | hsa-miR-29c-3p | Astrocytoma | MNDR-E-MI-35505 |
| MNDR | hsa-miR-29c-3p | Glioma | MNDR-E-MI-35506 |
| MNDR | hsa-miR-29c-3p | Nemaline myopathy | MNDR-E-MI-35507 |
| MNDR | hsa-miR-29c-3p | Peripheral nerve sheath tumours | MNDR-E-MI-35508 |
| MNDR | hsa-miR-29c-3p | Central nervous system lymphoma | MNDR-E-MI-35509 |
| MNDR | hsa-miR-29c-3p | Rhabdomyosarcoma | MNDR-E-MI-35510 |
| MNDR | hsa-miR-29c-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-35511 |
| MNDR | hsa-miR-29c-3p | Epilepsy temporal lobe | MNDR-E-MI-35512 |
| MNDR | hsa-miR-29c-3p | Osteosarcoma | MNDR-E-MI-35513 |
| MNDR | hsa-miR-29c-3p | Liposarcoma | MNDR-E-MI-35514 |
| MNDR | hsa-miR-29c-3p | Inclusion body myositis | MNDR-E-MI-35515 |
| MNDR | hsa-miR-29c-3p | Meningioma | MNDR-E-MI-35516 |
| MNDR | hsa-miR-29c-3p | Gastric adenocarcinoma | MNDR-E-MI-35517 |
| MNDR | hsa-miR-29c-3p | Cervical squamous cell carcinoma | MNDR-E-MI-35518 |
| MNDR | hsa-miR-29c-3p | Lung squamous cell carcinoma | MNDR-E-MI-35519 |
| MNDR | hsa-miR-29c-3p | Adrenocortical carcinoma | MNDR-E-MI-35520 |
| MNDR | hsa-miR-29c-3p | Thyroid carcinoma | MNDR-E-MI-35521 |
| MNDR | hsa-miR-29c-3p | Papillary thyroid carcinoma | MNDR-E-MI-35522 |
| MNDR | hsa-miR-29c-3p | Ovarian carcinoma | MNDR-E-MI-35523 |
| MNDR | hsa-miR-29c-3p | Bladder urothelial carcinoma | MNDR-E-MI-35524 |
| MNDR | hsa-miR-29c-3p | Brain stem cancer | MNDR-E-MI-35525 |
| MNDR | hsa-miR-29c-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-35526 |
| MNDR | hsa-miR-29c-3p | Carcinoma renal cell | MNDR-E-MI-35527 |
| MNDR | hsa-miR-29c-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-35528 |
| MNDR | hsa-miR-29c-3p | Renal clear cell carcinoma | MNDR-E-MI-35529 |
| MNDR | hsa-miR-29c-3p | Cholangiocarcinoma | MNDR-E-MI-35530 |
| MNDR | hsa-miR-29c-3p | Esophageal cancer | MNDR-E-MI-35531 |
| MNDR | hsa-miR-29c-3p | Lung small cell carcinoma | MNDR-E-MI-35532 |
| MNDR | hsa-miR-29c-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-35533 |
| MNDR | hsa-miR-29c-3p | Testicular germ cell cancer | MNDR-E-MI-35534 |
| MNDR | hsa-miR-29c-3p | T acute lymphoblastic leukemia | MNDR-E-MI-35535 |
| MNDR | hsa-miR-29c-3p | HBV+ hepatocellular carcinoma | MNDR-E-MI-35536 |
| MNDR | hsa-miR-29c-3p | Familiar ovarian carcinoma | MNDR-E-MI-35537 |
| MNDR | hsa-miR-29c-3p | Aggressive b-cell lymphoma | MNDR-E-MI-35538 |
| MNDR | hsa-miR-29c-3p | Rheumatoid arthritis | MNDR-E-MI-35539 |
| MNDR | hsa-miR-29c-3p | T-cell leukemia | MNDR-E-MI-35540 |
| MNDR | hsa-miR-29c-3p | Retinoblastoma | MNDR-E-MI-35541 |
| MNDR | hsa-miR-29c-3p | Neuroblastoma | MNDR-E-MI-35542 |
| MNDR | hsa-miR-29c-3p | Barrett's adenocarcinoma | MNDR-E-MI-35543 |
| MNDR | hsa-miR-29c-3p | Chronic myelogenous leukemia | MNDR-E-MI-35544 |
| MNDR | hsa-miR-29c-3p | Hodgkin lymphoma | MNDR-E-MI-35545 |
| MNDR | hsa-miR-29c-3p | Burkitt lymphoma | MNDR-E-MI-35546 |
| MNDR | hsa-miR-29c-3p | Tonsil cancer | MNDR-E-MI-35547 |
| MNDR | hsa-miR-29c-3p | Skin cutaneous melanoma | MNDR-E-MI-35548 |
| MNDR | hsa-miR-29c-3p | Skin melanoma | MNDR-E-MI-35549 |
| MNDR | hsa-miR-29c-3p | Colorectal cancer | MNDR-E-MI-35550 |
| MNDR | hsa-miR-29c-3p | Nasopharyngeal carcinoma | MNDR-E-MI-35551 |
| MNDR | hsa-miR-29c-3p | Type 2 diabetes mellitus | MNDR-E-MI-35552 |
| MNDR | hsa-miR-29c-3p | Multiple myeloma | MNDR-E-MI-35553 |
| MNDR | hsa-miR-29c-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-35554 |
| MNDR | hsa-miR-29c-3p | Ependymoma | MNDR-E-MI-35555 |
| MNDR | hsa-miR-29c-3p | Cardiomegaly | MNDR-E-MI-35556 |
| MNDR | hsa-miR-29c-3p | Nasopharyngeal cancer | MNDR-E-MI-35557 |
| MNDR | hsa-miR-29c-3p | Prostatic neoplasms | MNDR-E-MI-35558 |
| MNDR | hsa-miR-29c-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-35559 |
| MNDR | hsa-miR-29c-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-35560 |
| MNDR | hsa-miR-29c-3p | Sarcopenia | MNDR-E-MI-35561 |
| MNDR | hsa-miR-29c-3p | Stroke lacunar | MNDR-E-MI-35562 |
| MNDR | hsa-miR-29c-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-35563 |
| MNDR | hsa-miR-29c-3p | Barrett's carcinogenesis | MNDR-E-MI-35564 |
| MNDR | hsa-miR-29c-3p | HPV | MNDR-E-MI-35565 |
| MNDR | hsa-miR-29c-3p | Low grade dysplastic nodule | MNDR-E-MI-35566 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADAM12 | Homo sapiens | RR00040365 |
TOP